Across TCGA pan-cancer cohorts, MIR6131 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR6131’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MIR6131 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR6131 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.
LUSC, LUAD, and UCEC are the cancer types where MIR6131 tumor–normal differential expression is most reproducible.